Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Lymphangioleiomyomatosis × Hydroxychloroquine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Multiple Myeloma 3 Unspecified Adult Solid Tumor, Protocol Specific 2 Solid Tumor 2 Pancreatic Neoplasms 2 Neoplasms 2 Refractory or Relapsed Solid Tumors 1 Recurrence 1 Neoplasms, Plasma Cell 1 Melanoma 1 Malignant Solid Tumour 1 Lymphangioleiomyomatosis 1 Leukemia, Myeloid, Acute 1 Leukemia 1 Gastrointestinal Neoplasms 1 Estrogen Receptor Positive Breast Cancer 1 Colorectal Neoplasms 1 Carcinoma, Renal Cell 1 Carcinoma, Non-Small-Cell Lung 1 Bone Metastases 1 Adult Solid Neoplasm 1

Interventions

Sirolimus 2 temsirolimus 1 saracatinib 1 Valproic Acid 1 Immunoglobulin G 1 Imatinib Mesylate 1 Hydroxychloroquine 1 Disulfides 1 Cetuximab 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01687179 2018-10-11

SAIL

Brigham and Women's Hospital

Phase 1 Completed

14 enrolled 14 charts

Lymphangioleiomyomatosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡